{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:07:03Z","timestamp":1785434823738,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s11095-010-0093-y","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T16:09:47Z","timestamp":1268755787000},"page":"145-158","source":"Crossref","is-referenced-by-count":40,"title":["Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array"],"prefix":"10.1007","volume":"28","author":[{"given":"Zhi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Romeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon F. A.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke A.","family":"Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"93_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720109789000537","volume":"6","author":"P Simerska","year":"2009","unstructured":"Simerska P, Moyle PM, Olive C, Toth I. Oral vaccine delivery\u2014new strategies and technologies. Curr Drug Deliv. 2009;6:347\u201358.","journal-title":"Curr Drug Deliv"},{"key":"93_CR2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/14760584.7.9.1329","volume":"7","author":"JA Mikszta","year":"2008","unstructured":"Mikszta JA, Laurent PE. Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook. Expert Rev Vaccines. 2008;7:1329\u201339.","journal-title":"Expert Rev Vaccines"},{"key":"93_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860701637966","volume":"16","author":"B Slutter","year":"2008","unstructured":"Slutter B, Hagenaars N, Jiskoot W. Rational design of nasal vaccines. J Drug Target. 2008;16:1\u201317.","journal-title":"J Drug Target"},{"key":"93_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/14760584.6.2.213","volume":"6","author":"D Lu","year":"2007","unstructured":"Lu D, Hickey AJ. Pulmonary vaccine delivery. Expert Rev Vaccines. 2007;6:213\u201326.","journal-title":"Expert Rev Vaccines"},{"key":"93_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.smim.2005.05.009","volume":"17","author":"J Valladeau","year":"2005","unstructured":"Valladeau J, Saeland S. Cutaneous dendritic cells. Semin Immunol. 2005;17:273\u201383.","journal-title":"Semin Immunol"},{"key":"93_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/14760584.2.2.253","volume":"2","author":"GM Glenn","year":"2003","unstructured":"Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines. 2003;2:253\u201367.","journal-title":"Expert Rev Vaccines"},{"key":"93_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"JD Bos","year":"2000","unstructured":"Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9:165\u20139.","journal-title":"Exp Dermatol"},{"key":"93_CR8","unstructured":"Gerstel MS, Place VA. Drug delivery device, US, 1976."},{"key":"93_CR9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","volume":"87","author":"S Henry","year":"1998","unstructured":"Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87:922\u20135.","journal-title":"J Pharm Sci"},{"key":"93_CR10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","volume":"56","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56:581\u20137.","journal-title":"Adv Drug Deliv Rev"},{"key":"93_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2009.01.025","volume":"136","author":"Z Ding","year":"2009","unstructured":"Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB\/c mice. J Control Release. 2009;136:71\u20138.","journal-title":"J Control Release"},{"key":"93_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1013607400040","volume":"19","author":"JA Matriano","year":"2002","unstructured":"Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res. 2002;19:63\u201370.","journal-title":"Pharm Res"},{"key":"93_CR13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.vaccine.2005.09.049","volume":"24","author":"G Widera","year":"2006","unstructured":"Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine. 2006;24:1653\u201364.","journal-title":"Vaccine"},{"key":"93_CR14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0006-3495(03)74917-0","volume":"84","author":"G Cevc","year":"2003","unstructured":"Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J. 2003;84:1010\u201324.","journal-title":"Biophys J"},{"key":"93_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbamem.2004.01.006","volume":"1663","author":"G Cevc","year":"2004","unstructured":"Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta. 2004;1663:61\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"93_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0005-2736(03)00172-X","volume":"1614","author":"G Cevc","year":"2003","unstructured":"Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim Biophys Acta. 2003;1614:156\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"93_CR17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/17425247.3.6.727","volume":"3","author":"HA Benson","year":"2006","unstructured":"Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3:727\u201337.","journal-title":"Expert Opin Drug Deliv"},{"key":"93_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200342050-00004","volume":"42","author":"G Cevc","year":"2003","unstructured":"Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet. 2003;42:461\u201374.","journal-title":"Clin Pharmacokinet"},{"key":"93_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5173(99)00361-0","volume":"194","author":"J Guo","year":"2000","unstructured":"Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm. 2000;194:201\u20137.","journal-title":"Int J Pharm"},{"key":"93_CR20","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1016\/j.vaccine.2006.03.011","volume":"24","author":"D Mishra","year":"2006","unstructured":"Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine. 2006;24:4847\u201355.","journal-title":"Vaccine"},{"key":"93_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1211\/0022357055515","volume":"57","author":"PN Gupta","year":"2005","unstructured":"Gupta PN, Mishra V, Singh P, Rawat A, Dubey P, Mahor S, et al. Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol. 2005;57:295\u2013301.","journal-title":"J Pharm Pharmacol"},{"key":"93_CR22","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1023\/A:1026191402557","volume":"20","author":"PL Honeywell-Nguyen","year":"2003","unstructured":"Honeywell-Nguyen PL, Arenja S, Bouwstra JA. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm Res. 2003;20:1619\u201325.","journal-title":"Pharm Res"},{"key":"93_CR23","first-page":"257","volume":"12","author":"PL Honeywell-Nguyen","year":"2002","unstructured":"Honeywell-Nguyen PL, Van den Bussche MH, Junginger HE, Bouwstra JA. The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin. STP Pharma. 2002;12:257\u201362.","journal-title":"STP Pharma"},{"key":"93_CR24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.0022-202X.2004.23441.x","volume":"123","author":"PL Honeywell-Nguyen","year":"2004","unstructured":"Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol. 2004;123:902\u201310.","journal-title":"J Invest Dermatol"},{"key":"93_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5173(99)00441-X","volume":"196","author":"GM Maghraby El","year":"2000","unstructured":"El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm. 2000;196:63\u201374.","journal-title":"Int J Pharm"},{"key":"93_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10611860802228673","volume":"16","author":"Z Ding","year":"2008","unstructured":"Ding Z, Bivas-Benita M, Hirschberg H, Kersten GFA, Jiskoot W, Bouwstra JA. Preparation and characterization of diphtheria toxoid-loaded elastic vesicles for transcutaneous immunization. J Drug Target. 2008;16:555\u201363.","journal-title":"J Drug Target"},{"key":"93_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0076-6879(83)91014-5","volume":"91","author":"GL Peterson","year":"1983","unstructured":"Peterson GL. Determination of total protein. Methods Enzymol. 1983;91:95\u2013119.","journal-title":"Methods Enzymol"},{"key":"93_CR28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/377287","volume":"188","author":"R Tierney","year":"2003","unstructured":"Tierney R, Beignon AS, Rappuoli R, Muller S, Sesardic D, Partidos CD. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses. J Infect Dis. 2003;188:753\u20138.","journal-title":"J Infect Dis"},{"key":"93_CR29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2006.11.009","volume":"117","author":"FJ Verbaan","year":"2007","unstructured":"Verbaan FJ, Bal SM, van den Berg DJ, Groenink WH, Verpoorten H, Luttge R, et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Control Release. 2007;117:238\u201345.","journal-title":"J Control Release"},{"key":"93_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(01)00576-2","volume":"217","author":"BA Bergh van den","year":"2001","unstructured":"van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm. 2001;217:13\u201324.","journal-title":"Int J Pharm"},{"key":"93_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2003.08.003","volume":"22","author":"B Metz","year":"2003","unstructured":"Metz B, Jiskoot W, Hennink WE, Crommelin DJ, Kersten GF. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine. 2003;22:156\u201367.","journal-title":"Vaccine"},{"key":"93_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-1157(74)90016-X","volume":"2","author":"K Miyamura","year":"1974","unstructured":"Miyamura K, Tajiri E, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J Biol Stand. 1974;2:203\u20139.","journal-title":"J Biol Stand"},{"key":"93_CR33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0304-4165(02)00415-4","volume":"1573","author":"PL Honeywell-Nguyen","year":"2002","unstructured":"Honeywell-Nguyen PL, de Graaff AM, Groenink HW, Bouwstra JA. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta. 2002;1573:130\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"93_CR34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(97)00185-0","volume":"16","author":"A Paul","year":"1998","unstructured":"Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine. 1998;16:188\u201395.","journal-title":"Vaccine"},{"key":"93_CR35","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/jid.2008.356","volume":"129","author":"B Mahe","year":"2009","unstructured":"Mahe B, Vogt A, Liard C, Duffy D, Abadie V, Bonduelle O, et al. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol. 2009;129:1156\u201364.","journal-title":"J Invest Dermatol"},{"key":"93_CR36","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00018-005-4529-1","volume":"62","author":"CD Partidos","year":"2005","unstructured":"Partidos CD, Muller S. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy. Cell Mol Life Sci. 2005;62:1418\u201324.","journal-title":"Cell Mol Life Sci"},{"key":"93_CR37","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","volume":"44","author":"W Yan","year":"2007","unstructured":"Yan W, Chen W, Huang L. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Mol Immunol. 2007;44:3672\u201381.","journal-title":"Mol Immunol"},{"key":"93_CR38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2008.06.016","volume":"35","author":"SM Bal","year":"2008","unstructured":"Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193\u2013202.","journal-title":"Eur J Pharm Sci"},{"key":"93_CR39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/17425240902841935","volume":"6","author":"AK Banga","year":"2009","unstructured":"Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv. 2009;6:343\u201354.","journal-title":"Expert Opin Drug Deliv"},{"key":"93_CR40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2005.04.004","volume":"22","author":"A Kissenpfennig","year":"2005","unstructured":"Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22:643\u201354.","journal-title":"Immunity"},{"key":"93_CR41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","volume":"25","author":"ST Reddy","year":"2007","unstructured":"Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O\u2019Neil CP, et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007;25:1159\u201364.","journal-title":"Nat Biotechnol"},{"key":"93_CR42","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.177.2.1250","volume":"177","author":"G Iezzi","year":"2006","unstructured":"Iezzi G, Frohlich A, Ernst B, Ampenberger F, Saeland S, Glaichenhaus N, et al. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J Immunol. 2006;177:1250\u20136.","journal-title":"J Immunol"},{"key":"93_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2004.11.013","volume":"22","author":"M Sixt","year":"2005","unstructured":"Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity. 2005;22:19\u201329.","journal-title":"Immunity"},{"key":"93_CR44","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11095-009-9874-6","volume":"26","author":"Z Ding","year":"2009","unstructured":"Ding Z, Van Riet E, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA. Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB\/c mice after microneedle array pretreatment. Pharm Res. 2009;26:1635\u201343.","journal-title":"Pharm Res"},{"key":"93_CR45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","volume":"112","author":"ST Reddy","year":"2006","unstructured":"Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, Swartz MA. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006;112:26\u201334.","journal-title":"J Control Release"},{"key":"93_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425247.3.3.345","volume":"3","author":"A Saupe","year":"2006","unstructured":"Saupe A, McBurney W, Rades T, Hook S. Immunostimulatory colloidal delivery systems for cancer vaccines. Expert Opin Drug Deliv. 2006;3:345\u201354.","journal-title":"Expert Opin Drug Deliv"},{"key":"93_CR47","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1517\/14712598.4.11.1735","volume":"4","author":"JG Altin","year":"2004","unstructured":"Altin JG, van Broekhoven CL, Parish CR. Targeting dendritic cells with antigen-containing liposomes: antitumour immunity. Expert Opin Biol Ther. 2004;4:1735\u201347.","journal-title":"Expert Opin Biol Ther"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11095-010-0093-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T07:21:12Z","timestamp":1551252072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0093-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0093-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}